BALA CYNWYD, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Predictive Oncology Inc. (Nasdaq - POAI)
Under the terms of the agreement, Predictive Oncology will be acquired by Renovaro Inc. (Nasdaq - RENB). Predictive Oncology will be merged into Renovaro in exchange for a newly created series of preferred stock of Renovaro. The investigation concerns whether the Predictive Oncology Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including any dilution of the Company’s shareholders in the combined company.
Additional information can be found at https://www.brodskysmith.com/cases/predictive-oncology-inc-nasdaq-poai/.
SunLink Health Systems, Inc. (NYSE American - SSY)
Under the terms of the Merger Agreement, SunLink Health will be acquired by Regional Health Properties, Inc. (“Regional”) (NYSE American: RHE) (NYSE American: RHE-PA). As a result of the transaction, SunLink shareholders will own approximately 43.0% of the combined company. The investigation concerns whether the SunLink Health Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of the Company’s shareholders in the combined company.
Additional information can be found at https://www.brodskysmith.com/cases/sunlink-health-systems-inc-nyse-american-ssy/.
Patterson Companies, Inc. (Nasdaq - PDCO)
Under the terms of the agreement, Patterson Companies will be acquired by Patient Square Capital for $31.35 per share in an all-cash transaction valued at approximately $4.1 billion, including the refinancing of Patterson’s receivables facilities. The investigation concerns whether the Patterson Companies Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal offers fair value to the Company’s shareholders.
Additional information can be found at https://www.brodskysmith.com/cases/patterson-companies-inc-nasdaq-pdco/
Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP)
Under the terms of the agreement, Universal will be acquired by Aperam for $45.00 per share in an all-cash transaction. The investigation concerns whether the Universal Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal offers fair value to the Company’s shareholders.
Additional information can be found at https://www.brodskysmith.com/cases/universal-stainless-alloy-products-inc-nasdaq-usap/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
